- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Merck KGaA (MRCG)
Track today's live Merck (MRCG) share price, performance and key data on this page with our current Xetra:MRCG stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Merck share price on the Xetra exchange. Use the dropdown to switch exchange for the MRCG share price, head to our technical summary section, which provides analysis on Merck share price buy/sell indicators using real-time data (or discuss the Merck (MRCG) stock price today with other investors in the Merck ETR share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ETR:MRCG share price (ISIN: DE0006599905) to enhance your trading decisions with our free investment tools and resources.
What Is the Merck KGaA Share Price Today?
The Merck share price today is 140.00.
What Is the Stock Symbol for Merck KGaA
The stock symbol (or 'ticker') for Merck KGaA is "MRCG."
What Stock Exchange Does Merck KGaA Trade On?
Merck KGaA is listed and trades on the Xetra stock exchange.
Is Merck KGaA a Good Stock to Buy?
Determining whether Merck (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current ETR:MRCG share price (ISIN: DE0006599905) to enhance your trading decisions with our free investment tools and resources.
What Is the Merck KGaA Share Price Today?
The Merck share price today is 140.00.
What Is the Stock Symbol for Merck KGaA
The stock symbol (or 'ticker') for Merck KGaA is "MRCG."
What Stock Exchange Does Merck KGaA Trade On?
Merck KGaA is listed and trades on the Xetra stock exchange.
Is Merck KGaA a Good Stock to Buy?
Determining whether Merck (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
140.00
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
138.75
140.00
52 wk Range
100.70
148.80
MRCG is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
138.75140.00
52 wk Range
100.70148.80
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.57%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.57%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MRCG Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
151.14
Upside
+7.96%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with low price volatility
Germany shares mixed at close of trade; DAX up 0.27%- Investing.com
- Germany shares mixed at close of trade; DAX up 0.27%
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
6 Buy
8 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 151.14
(+7.96% Upside)
Earnings
Latest Release
06/08/2026
EPS / Forecast
2.16 / 2.00
Revenue / Forecast
5.43B / 5.25B
Compare MRCG to Peers and Sector
Metrics to compare | MRCG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMRCGPeersSector | |
|---|---|---|---|---|
P/E Ratio | 25.6x | 29.6x | −0.4x | |
PEG Ratio | −1.48 | −0.07 | 0.00 | |
Price/Book | 2.0x | 2.0x | 2.6x | |
Price / LTM Sales | 2.9x | 2.4x | 3.1x | |
Upside (Analyst Target) | 8.4% | 17.9% | 47.5% | |
Fair Value Upside | Unlock | 5.5% | 5.9% | Unlock |
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Merck (Xetra: MRCG) Share Price Today?
The Merck stock price today is 140.00 EUR.
What Stock Exchange Does Merck (MRCG) Trade On?
Merck is listed and trades on the Frankfurt Stock Exchange.
What Is the Ticker (Stock Symbol) for Merck?
The stock symbol (also called a 'ticker') for Merck is "MRCG."
Does Merck Pay Dividends? What’s The Current MRCG Dividend Yield?
Yes, MRCG Pays Dividends to its Shareholders. The current Merck dividend yield is 1.57%.
What Is the Current Merck Market Capitalisation?
As of today, Merck (Xetra: MRCG) market cap is 60.87B EUR.
What Is Merck's (MRCG) Earnings Per Share (TTM)?
The Merck EPS is currently 5.45 (Trailing Twelve Months).
When Is the Next Merck Earnings Date?
Merck's next earnings report will be released on 12/11/2026.
Is MRCG a Buy or Sell From a Technical Analyst Perspective?
Based on today's Merck moving averages and other technical indicators, the daily buy/sell signal for MRCG stock is Neutral.
How Many Times Has Merck Stock Split?
Merck has split 2 times. (See the MRCG stock split history page for full effective split date and price information.)
How Many Employees Does Merck Have?
Merck has 62136 employees, based on their latest Companies House report.
What is the current trading status of Merck (Xetra: MRCG)?
As of 12/08/2026, Merck (MRCG) is trading at a share price of 140.00 EUR, with a previous close of 140.00 EUR. The stock has fluctuated within a day range of 138.75 EUR to 140.00 EUR, while its 52-week range spans from 100.70 EUR to 148.80 EUR.
What Is Merck (MRCG) Price Target According to Analysts?
The average 12-month price target for Merck is 151.14 EUR, with a high estimate of 179 EUR and a low estimate of 129 EUR. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +7.96% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.